Bioprinting is in the vanguard of the war against the novel coronavirus and holds promise for greater understanding of the way SAR-CoV-2 works in the human body.
Displaying 1-10 of 20 results for
In January, as the new coronavirus was rapidly spreading around the world, scientists at Moderna teamed up with the National Institutes of Health to pursue a potential vaccine based on an experimental genetic technology involving messenger RNA (mRNA), a molecule in every cell that helps translate DNA into biological functions.
A dozen Boston area anesthesiology residents have launched an eight-week hackathon hosted on GrabCAD.com to design a rapidly deployable, minimum viable mechanical ventilator for patients with COVID-19-related ventilator-dependent lung injury.
Over 150 organizations responding to pandemic. Requests from hospitals and other organizations exceed 350,000 shields; first hospital shipment received on Mar. 25
Stratasys and Origin have signed an agreement in which Stratasys will market and promote Origin 3D-printed nasopharyngeal (NP) swabs to healthcare providers and other testing centers in the U.S.
In the U.S., we are not seeing any specific localized disruption yet, although I’m watching New Jersey where it could be on the cusp. There are a lot of manufacturing facilities there in pharmaceuticals and chemicals, and therefore that’s an area I think we should be paying attention to.
Stratasys Ltd., the 3D printing company, says its own customer base prompted it to become involved in responding to the novel coronavirus (COVID-19).
The impact of COVID-19 has changed the way we conduct business, and now, more than ever, illuminates the need for manufacturers to assess their processes and implement smart manufacturing technology.
UL says the novel coronavirus (COVID-19) has increased cybersecurity problems for manufacturers.
A panel of experts and startups in medical 3D printing provided insights into efforts to help the COVID-19 pandemic in a webinar organized by 3DHEALS